REVB (Revelation Biosciences) Utang jangka cendhak marang modal

Logo korporat perusahaan Revelation Biosciences (REVB)

The market dynamics of Revelation Biosciences (REVB) reflected in the quotes on GURU.Markets show a debt-to-equity ratio of 0.02. The immune therapy developer integrates ESG principles and bioethics into its scientific research, reducing harmful emissions. The implementation of automated cytokine analysis systems optimizes personnel costs. The expected completion of primary tests for new drugs will serve as a growth driver, despite current R&D expenses.

Rasio tanggungan utang jangka cendhak marang modal: Revelation Bio (REVB) kanggo 04.07.2022 - 30.10.2026
Produk merek Revelation Biosciences Inc

For Revelation Biosciences (REVB), which is scaling clinical trials for immunomodulators, the short-term debt-to-equity ratio reflects the current dependence of operational activities on quick loans. This metric correlates liabilities with a maturity of up to one year against total equity, allowing investors to assess liquidity risk and balance sheet resilience to market shocks while awaiting molecular data.

Pesaing utama

Utang jangka cendhak marang modal ARGX|BNTX (BioNTech Pharma) - Rasio tanggungan utang jangka cendhak marang modal|Utang jangka cendhak marang modal ABVX (Abivax Pharma)|Utang jangka cendhak marang modal admabiologics.com ADMA|PTGX - Utang jangka cendhak marang ekuitas|Rasio tanggungan utang jangka cendhak marang modal IMVT (Immunovant Inc)|Kiniksa Pharmaceuticals Ltd (KNSA) - Utang jangka cendhak marang ekuitas|Rasio utang jangka cendhak marang ekuitas Grifols Biemat|ADPT (Adaptive Biotechnologies) - Utang jangka cendhak marang modal|Utang jangka cendhak marang modal celldex.com|Rasio utang jangka cendhak marang ekuitas AUPH (Aurinia Pharmaceuticals Inc.)|BCRX (BioCryst Pharmaceuticals, Inc.) - Rasio tanggungan utang jangka cendhak marang modal|Utang jangka cendhak marang modal VERA (Vera Pharma)|Koefisien utang jangka cendhak marang modal Dianthus Corp (DNTH)|PHVS - Utang jangka cendhak marang ekuitas|AbCellera Biologics Inc (ABCL) - Rasio utang jangka cendhak marang ekuitas|Tourmaline Bio (TRML) - Utang jangka cendhak marang ekuitas|Rasio utang jangka cendhak marang ekuitas Precigen Inc|Rasio utang jangka cendhak marang ekuitas PHAR|Utang jangka cendhak marang modal Nektar Corp|Utang jangka cendhak marang ekuitas Upstream Bio Inc (UPB)|zenasbio.com - Rasio utang jangka cendhak marang modal|Utang jangka cendhak marang modal IMNM (Immunome)|Gossamer Bio Inc (GOSS) - Kewajiban jangka cendhak marang modal|KALV - Utang jangka cendhak marang ekuitas|Rasio tanggungan utang jangka cendhak marang modal SEPN (Septerna Pharma)|PVLA: Utang jangka cendhak marang modal|Kewajiban jangka cendhak marang modal savarapharma.com (SVRA)|Rasio utang jangka cendhak marang ekuitas RIGL|Utang jangka cendhak marang ekuitas ANAB|Utang jangka cendhak marang modal ATXS|ENGN - Kewajiban jangka cendhak marang modal|Utang jangka cendhak marang ekuitas RAPT Therapeutics RAPT|Aerovate Therapeutics, Inc. - Utang jangka cendhak marang ekuitas|Aclaris Therapeutics, Inc. - Utang jangka cendhak marang modal|KYTX - Utang jangka cendhak marang modal|TLSA (Tiziana Life Sciences PLC) - Rasio utang jangka cendhak marang ekuitas|CABA: Rasio silihan jangka cendhak marang modal|VTYX (Ventyx Biosciences) - Utang jangka cendhak marang modal|theratech.com (THTX) - Koefisien utang jangka cendhak marang modal|Utang jangka cendhak marang ekuitas Avalo Therapeutics (AVTX)|ELDN - Kewajiban jangka cendhak marang modal|Utang jangka cendhak marang ekuitas Agenus Inc AGEN|CLYM: Rasio utang jangka cendhak marang modal|ZURA: Rasio utang jangka cendhak marang ekuitas|Rasio tanggungan utang jangka cendhak marang modal ATYR (atyrpharma.com)|ADAG: Utang jangka cendhak marang modal|IMA (Ikena Oncology) - Utang jangka cendhak marang ekuitas|STTK (Shattuck Labs Inc) - Utang jangka cendhak marang modal|Equillium Bio (EQ) - Koefisien utang jangka cendhak marang modal|Utang jangka cendhak marang ekuitas Connect Biopharma (CNTB)|IMUX - Kewajiban jangka cendhak marang modal|Utang jangka cendhak marang ekuitas Atara Bio ATRA|Koefisien utang jangka cendhak marang modal InflaRx NV (IFRX)|X4 Pharma - Utang jangka cendhak marang modal|Adicet Bio (ACET) - Rasio utang jangka cendhak marang ekuitas|CELU: Utang jangka cendhak marang modal|INMB - Koefisien utang jangka cendhak marang modal|BRNS (Barinthus Biotherapeutics plc) - Utang jangka cendhak marang modal|Kewajiban jangka cendhak marang modal Kezar Life Sciences Inc. KZR|Utang jangka cendhak marang ekuitas SAB Biotherapeutics, Inc (SABS)|Akari Therapeutics, Plc - Rasio utang jangka cendhak marang modal|Utang jangka cendhak marang modal ENLV (Enlivex Therapeutics Ltd.)|QTTB - Rasio utang jangka cendhak marang ekuitas|GeoVax - Utang jangka cendhak marang modal|Kewajiban jangka cendhak marang modal Edesa Biotech Inc|iBio Corp (IBIO) - Utang jangka cendhak marang ekuitas|CARM - Koefisien utang jangka cendhak marang modal|Utang jangka cendhak marang ekuitas XTL Biopharmaceuticals|BOLT: Rasio tanggungan utang jangka cendhak marang modal|Utang jangka cendhak marang modal HCWB|APVO - Kewajiban jangka cendhak marang modal|AIM ImmunoTech Inc. - Rasio utang jangka cendhak marang ekuitas|Aditxt Inc. - Utang jangka cendhak marang ekuitas|GRI Bio, Inc. - Utang jangka cendhak marang modal|XRTX: Utang jangka cendhak marang ekuitas|Vyome Holdings (HIND) - Utang jangka cendhak marang ekuitas|Kewajiban jangka cendhak marang ekuitas INDP (Indaptus Therapeutics Inc)|SCNI (Scinai) - Utang jangka cendhak marang modal|CALI: Rasio tanggungan utang jangka cendhak marang modal|Utang jangka cendhak marang modal AFMD|Utang jangka cendhak marang modal allakos.com (ALLK)|Utang jangka cendhak marang ekuitas HOOKIPA Pharma HOOK|Rasio tanggungan utang jangka cendhak marang modal IGMS|ITOS - Utang jangka cendhak marang ekuitas|Ocean Biomedical Corp (OCEA) - Rasio utang jangka cendhak marang ekuitas|TCBP: Utang jangka cendhak marang modal|thirdharmonicbio.com (THRD) - Utang jangka cendhak marang modal